Approved indications: Fomepizole is FDA‑approved for the treatment of ethylene glycol poisoning and methanol poisoning, with or without concurrent hemodialysis.

Off‑label uses and evidence: It may be used off‑label as an adjunct in some rare toxic alcohol exposures (such as diethylene glycol) when alcohol dehydrogenase inhibition is considered beneficial, but data are limited and come mainly from case reports and small series.

Efficacy expectations: When started early after ingestion, fomepizole greatly reduces formation of toxic metabolites, often preventing severe metabolic acidosis, kidney failure, and vision loss; clinical stabilization of acid–base status may occur within hours, especially when combined with dialysis. Outcomes with fomepizole‑based regimens are generally favorable and at least comparable to, and often safer than, historical regimens using ethanol as the antidote, because fomepizole has more predictable dosing and fewer CNS and metabolic side effects.

Typical dosing: For ethylene glycol or methanol poisoning, adults and children generally receive an initial intravenous loading dose of 15 mg/kg, followed by 10 mg/kg every 12 hours for four doses; if needed, subsequent doses are increased (commonly to 15 mg/kg every 12 hours) until toxic alcohol levels are safe and the patient is clinically stable. Dosing intervals are shortened and/or additional doses are given during hemodialysis because the drug is removed by dialysis.

How it is given: Fomepizole is administered only by IV infusion in a healthcare facility, over at least 30 minutes, often alongside supportive measures such as bicarbonate and hemodialysis; it is not taken by mouth and is not a home medication.

Special dosing instructions: Dosing is individualized based on body weight, timing and amount of ingestion, toxic alcohol blood levels, acid–base status, and whether dialysis is being used; clinicians adjust the schedule accordingly and continue therapy until toxic alcohol concentrations are undetectable or clearly below toxic thresholds.

Missed doses and overdose: If a scheduled dose is delayed or missed in the hospital, clinicians generally administer it as soon as feasible and adjust subsequent timing to maintain adequate enzyme inhibition. Overdose with fomepizole itself is rare and occurs almost exclusively in the hospital; management is supportive, with monitoring of vital signs, labs, and consideration of dialysis if clinically indicated.

Common side effects: The most frequently reported effects include headache, nausea, dizziness, metallic taste, and mild infusion‑site reactions or pain; these are usually transient and mild to moderate in severity.

Serious or rare adverse effects: Rare events can include allergic or hypersensitivity reactions (such as rash, urticaria, or in very rare cases anaphylaxis), liver enzyme elevations, and, in critically ill patients, worsening of underlying instability. Any trouble breathing, swelling of the face or throat, or severe rash requires immediate emergency care.

Warnings and precautions: Fomepizole is used in all ages, including children, only in monitored settings. Data in pregnancy and breastfeeding are limited, but the drug is often used if the mother’s life or organ function are at risk, because untreated toxic alcohol poisoning is far more dangerous. Dose adjustments and close monitoring are important in patients with significant kidney or liver impairment, especially when combined with hemodialysis.

Safety compared with alternatives: Compared with ethanol therapy, fomepizole has a more favorable and predictable safety profile, with fewer CNS depressant effects, less risk of hypoglycemia, and simpler monitoring requirements.

Reporting side effects and safety updates: In the United States, suspected side effects can be reported to the FDA’s MedWatch program or to the manufacturer, and up‑to‑date safety communications are available through the FDA’s online drug safety resources.

Drug and substance interactions: Fomepizole works by inhibiting alcohol dehydrogenase and can blunt the metabolism of ethanol and other alcohols; concurrent ethanol administration is usually avoided unless specifically part of a planned regimen. No large set of major interactions with common prescription drugs, OTC medicines, or supplements is known, but because fomepizole is used in critically ill patients, clinicians carefully review all medications for overlapping toxicities and adjust as needed.

Food, alcohol, and procedures: Food does not have a meaningful effect because the drug is given intravenously. Intentional or ongoing ingestion of alcohols (such as antifreeze or methanol‑containing products) around the time of treatment is dangerous and requires urgent medical care. Fomepizole does not typically interfere with standard imaging or diagnostic procedures, though blood tests for toxic alcohol levels and metabolic parameters guide its use.

Precautions and monitoring: Use is reserved for settings with close monitoring of vital signs, neurologic status, acid–base balance, kidney function, liver enzymes, and toxic alcohol concentrations. Extra caution is required in severe liver disease, advanced kidney failure, pregnancy, and in patients receiving multiple potentially hepatotoxic or nephrotoxic drugs.

Q: What is fomepizole used for?
A: Fomepizole is an antidote used in the hospital to treat poisoning from ethylene glycol (such as in antifreeze) and methanol, helping prevent kidney damage, vision loss, and other serious harm.

Q: How quickly does fomepizole start working?
A: Fomepizole begins blocking the toxic metabolism of ethylene glycol and methanol soon after the first IV dose, and doctors usually see improvement in blood tests for acidity and toxic alcohol levels within hours, especially when combined with hemodialysis.

Q: Is fomepizole safer than ethanol treatment?
A: Yes, fomepizole is generally considered safer and easier to manage than ethanol therapy because it has more predictable effects, causes less sedation and hypoglycemia, and requires simpler monitoring.

Q: Can children or pregnant women receive fomepizole?
A: Fomepizole can be given to children of all ages and to pregnant women when needed, as the risk from untreated toxic alcohol poisoning is very high; dosing is based on body weight and patients are monitored closely.

Q: Can I get fomepizole from a pharmacy for home use?
A: No, fomepizole is an emergency antidote stocked in hospitals and some emergency centers and is given only under close medical supervision through an IV line.

Fomepizole is supplied and handled in healthcare settings, so patients typically do not store it at home.

In hospitals and clinics, it should be stored according to the manufacturer’s instructions, usually at controlled room temperature and protected from extreme heat or freezing.

Unused or expired vials are disposed of by healthcare staff as pharmaceutical hazardous waste, not in regular trash or down the drain.